ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,715Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 315

$683K Total Retail Price of All Prescriptions

Rank: 36 out of 315

386 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,044 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LOVASTATIN 373 364 1 8
METFORMIN HCL 333 305 2 7
AMLODIPINE BESYLATE 333 317 2 2
LISINOPRIL 291 260 4 3
METOPROLOL SUCCINATE 281 264 5 13
ATORVASTATIN CALCIUM 257 257 6 5
GLIPIZIDE 249 209 7 30
LOSARTAN POTASSIUM 227 217 8 4
LEVOTHYROXINE SODIUM 223 222 9 6
SIMVASTATIN 211 196 10 1
FUROSEMIDE 182 178 11 15
FELODIPINE ER 173 171 12 23
ALLOPURINOL 166 162 13 14
METOPROLOL TARTRATE 158 158 14 18
RANITIDINE HCL 152 141 15 42
DIGOXIN 135 135 16 45
HYDROCODONE-ACETAMINOPHEN 128 96 S3 17 19
OMEPRAZOLE 128 101 17 9
ISOSORBIDE MONONITRATE ER 103 103 19 92
GABAPENTIN 102 85 20 37
HYDROCHLOROTHIAZIDE 98 96 21 16
DOXAZOSIN MESYLATE 96 96 22 110
LIPITOR 92 92 23 44
TRIAMTERENE-HCTZ 86 84 24 71
AMOXICILLIN 83 83 25 65
WARFARIN SODIUM 81 71 26 20
DONEPEZIL HCL 81 81 26 28
FAMOTIDINE 80 80 28 75
SYNTHROID 78 78 29 51
CITALOPRAM HBR 78 63 29 72
TAMSULOSIN HCL 78 78 29 21
AZITHROMYCIN 76 71 32 39
PRAVASTATIN SODIUM 74 74 33 10
POTASSIUM CHLORIDE 70 70 34 36
VERAPAMIL ER 69 61 35 94
CLOPIDOGREL 68 68 36 25
PLAVIX 66 66 37 40
ATENOLOL 66 66 37 11
ZETIA 66 66 37 84
EVISTA 65 65 40 48
TERAZOSIN HCL 63 63 41 63
MELOXICAM 62 61 42 77
TRAZODONE HCL 62 59 42 93
PROPRANOLOL HCL 62 62 42 129
ZOLPIDEM TARTRATE 60 60 45 29
PREDNISONE 57 36 46 41
CIPROFLOXACIN HCL 56 53 47 58
AMITRIPTYLINE HCL 55 33 R 48 179
NEXIUM 54 53 49 54
PANTOPRAZOLE SODIUM 54 54 49 35
ONGLYZA 54 46 49 99
OXYCODONE HCL 53 38 S2 52 57
LOSARTAN-HYDROCHLOROTHIAZIDE 50 47 53 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.